logo

DMAA

Drugs Made In·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
4.19 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Trend Analysis of DMAA
  • Based on a composite score of 4.19/10, we rate DMAA as a Netural. Our analysis breaks down into 2.26/10 for Fundamentals, 4.38/10 for Technicals, and 5.92/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is DMAA undervalued or overvalued?
Technical Analysis of DMAA?
Is money flowing into or out of DMAA?